Natco rolls out Baricitinib ahead of approval for patent waiver

Even as it has filed for a compulsory licence for Covid-19 drug Baricitinib in India, Natco Pharma has already begun rolling out its generic version of the rheumatoid arthritis drug under the Barinat brand.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3trt98X
via IFTTT